1,019 results on '"Fehse, Boris"'
Search Results
2. Cellular Therapy with Engineered T Cells, Efficacy, and Side Effects: Gene Editing/Gene Therapy
3. Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoire
4. Erratum zu: Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft
5. Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR
6. Genome-Editing – Gentherapie 2.0 oder nur eine Wunschvorstellung?
7. Hämatopoetische Stammzelltransplantation: seit Jahrzehnten etablierte Zelltherapie
8. Einleitung: Gen- und Zelltherapie – 'zwei Seiten zweier Medaillen'
9. Handlungsempfehlungen zur somatischen Gentherapie, Keimbahninterventionen und Zelltherapie
10. Retrovirale Vektoren – Effiziente Gentaxis für unterschiedliche Gentherapien
11. Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis
12. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction
13. Chaperone-mediated autophagy in neuronal dendrites utilizes activity-dependent lysosomal exocytosis for protein disposal
14. Erratum zu: Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft
15. Microglia colonize the developing brain by clonal expansion of highly proliferative progenitors, following allometric scaling
16. Immune Monitoring
17. Somatische Gentherapie vs. Keimbahnmodifikation
18. Genome Editing
19. Klassische Gentherapie
20. Elevated levels of Protein S in Multiple Myeloma bone marrow microenvironment regulate tumor progression and bone disease
21. Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft
22. Ausblick
23. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
24. CARs come to AID
25. An antigen-specific chimeric autoantibody receptor NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
26. CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture
27. Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis
28. Automated production of CCR5-negative CD4+-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients
29. Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
30. Retroviral gene therapy in Germany with a view on previous experience and future perspectives
31. Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting
32. Correction: Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
33. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2
34. Einleitung
35. Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods
36. The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the TK.007 System.
37. Cellular Therapy with Engineered T Cells, Efficacy and Side Effects
38. Glioma escape signature and clonal development under immune pressure
39. Spectrum of ASXL1 Mutations Show Similar Impact on Outcomes in Patients with Myelofibrosis Undergoing Transplantation
40. How to package and SEND mRNA: a novel “humanized” vector system based on endogenous retroviruses
41. Vertically transferred maternal immune cells promote neonatal immunity against early life infections
42. In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets
43. mRNA Transfection of T-Lymphocytes by Electroporation
44. Anwendung des Genome Editing in der somatischen Gentherapie
45. 9. Genome-Editing und Einzelzellanalyse: Neue Methoden und ihre Implikationen für Forschung, Anwendung und Gesellschaft
46. 1. Einleitung
47. 6. Themenbereich somatische Gentherapie: aus dem Labor über klinische Studien zum kommerziellen Einsatz
48. Development of CAR-T cell therapies for multiple myeloma
49. An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
50. Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.